Sc Liver Research Consortium, LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Optimization for Regorafenib in HCC

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2020-07-20
Last Posted Date
2021-12-30
Lead Sponsor
SC Liver Research Consortium, LLC
Target Recruit Count
7
Registration Number
NCT04476329
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Tulane University, New Orleans, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Comprehensive Cancer Centers of Nevada, Henderson, Nevada, United States

and more 6 locations

SMV + SOF With/Without RBV for IFN-II Patients With CHC

Phase 4
Completed
Conditions
Interventions
First Posted Date
2014-08-12
Last Posted Date
2018-06-19
Lead Sponsor
SC Liver Research Consortium, LLC
Target Recruit Count
24
Registration Number
NCT02214420
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Scripps Clinic, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Research Centers of America, LLC, Murray, Utah, United States

๐Ÿ‡บ๐Ÿ‡ธ

Icahn School of Medicine at Mt. Sinai, New York, New York, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath